Use of the Pill Questionnaire to detect cognitive deficits and assess their impact on daily life in patients with Parkinson's disease

Neurology Asia

Volumn 18, Issue 4, 2013, Pages 369-375

  Kim, Ji Seon ^a   Kim, Jong Min ^b   Kim, Hee Jin ^c   Yun, Ji Young ^d   Jeon, Beom S ^e  

^a Chungbuk National University College of Medicine   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Konkuk University Hospital   (South Korea)

^d Ewha Womans University   (South Korea)

^e Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT;

AGED; ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL DEMENTIA RATING SCORE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; FUNCTIONAL DISEASE; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; MOTOR DYSFUNCTION; PARKINSON DISEASE; PATIENT ATTITUDE; PILL; PILL QUESTIONNAIRE; QUESTIONNAIRE; SCORING SYSTEM; SELF CARE;

EID: 84891133578     PISSN: 18236138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Aarsland D, Andersen K, Larsen J, Lolk A. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neuro. 2003; 60:387-82.
2. Aarsland D, Zaccai J, Brayne C. A systematic review of prevalence studies of dementia in Parkinson's disease. Mov Disord 2005; 20:1255-63.
3. Riedel O, Klotsche J, Spottke A, et al. Cognitive impairment in 873 patients with idiopathic Parkinson's disease. J Neurol 2008; 255:255-64.
4. Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psyhiatry 2000; 69:308-12.
5. Aarsland D, Larsen J, Karlsen K, Lim N, Tandberg E. Mental symptoms in Parkinson's disease are important contributors to caregiver distress. Int J Geriatr Psychiatry 1999; 14:866-74.
6. Marder K, Leung D, Tang M, et al. Are demented patients with Parkinson's disease accurately reflected in prevalence surveys? A survival analysis. Neurology 1991; 41:1240-3.
7. Lewis S, Foltynie T, Blackwell A, Robbins T, Owen A, Barker R. Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry 2005; 76:343-8.
8. Janvin CC, Aarsland D, Larsen JP. Cognitive predictors of dementia in Parkinson's disease: a community-based, 4-year longitudinal study. J Geriatr Psychiatry Neurol 2005; 18:149-54.
9. Dubois B, Burn D, Goetz C, et al. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord 2007; 22(16):2314-24.
10. Cahn DA, Sullivan EV, Shear PK, Pfefferbaum A, Heit G, Silverberg G. Differential contributions of cognitive and motor component processes to physical and instrumental activities of daily living in Parkinson's disease. Arch Clin Neuropsychol 1998; 13:575-83.
11. Rasovska H, Rektorova I. Instrumental activities of daily living in Parkinson's disease dementia as compared with Alzheimer's disease: Relationship to motor disability and cognitive deficits: A pilot study. J Neurol Sci 2011; 301:279-82.
12. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56:303-8.
13. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993; 43:2412-4.
14. Choi SH, Na DL, Lee BH, et al. Estimating the validity of the Korean version of expanded clinical dementia rating (CDR) scale. J Korean Neurol Assoc 2001; 19:585-91.
15. Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006; 5:235-45.
16. Lim SY, Lang AE. The nonmotor symptoms of Parkinson's disease-an overview. Mov Disord 2010; 25:S123-30.
17. Simuni T, Sethi K. Nonmotor manifestations of Parkinson's disease. Ann Neurol 2008; 64:S65-80.
18. Mahieux F, Michelet D, Manifacier MJ, Boller F, Fermanian J, Guillard A. Mini-Mental Parkinson: first validation study of a new bedside test constructed for Parkinson's disease. Behav Neurology 1995; 8:15-22.
19. Marinus J, Visser M, Verwey N, et al. Assessment of cognition in Parkinson's disease. Neurology 2003; 61:1222-8.
20. Pagonabarraga J, Kulisevsky J, Llebaria G, Garcia Sanchez C, Pascual Sedano B, Gironell A. Parkinson's disease cognitive rating scale: A new cognitive scale specific for Parkinson's disease. Mov Disord 2008; 23:998-1005.
21. Kulisevsky J, Pagonabarraga J. Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment. Mov Disord 2009; 24:1103-10.
22. Hoops S, Nazem S, Siderowf A, et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 2009; 73:1738-45.
23. Zadifoff C, Fox SH, Tang-Wai DF, et al. A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease. Mov Disord 2008; 23:297-9.
24. Nazem S, Siderowf AD, Duda JE, et al. Montreal Cognitive Assessment Performance in Patients with Parkinson's Disease with "Normal" Global Cognition According to Mini Mental State Examination Score. J Am Geriatr Soc 2009; 57:304-8.
25. Dujardin K, Dubois B, Tison F, et al. Parkinson's disease dementia can be easily detected in routine clinical practice. Mov Disord 2010; 25:2769-76.
26. Shulman LM, Pretzer-Aboff I, Anderson KE, et al. Subjective report versus objective measurement of activities of daily living in Parkinson's disease. Mov Disord 2006; 21:794-9.